About Us

The GLCC is the international ‘voice’ of lung cancer patients.

Established in 2001, the GLCC now comprises 43 non-government patient organisations from 30 nations: Argentina, Australia, Brazil, Bulgaria, Canada, Czech Republic, Denmark, Egypt, France, Germany, Greece, Ireland, Israel, Italy, Japan, Mexico, Netherlands, Norway, Peru, Portugal, Russia, Slovenia, South Africa, Spain, Sweden, Switzerland, Taiwan, Turkey, UK and US.

siteicon
Who We Are

By serving as the international voice of lung cancer patients, the Global Lung Cancer Coalition is committed to improving disease outcomes for all. Its programmatic efforts are focused around four key areas: Placing lung cancer squarely on the global health agenda Lessening the stigma of lung cancer among patients, their families, their health care providers, […]

Read more
siteicon
Patient Charter

The Global Lung Cancer Coalition Patient Charter is an affirmation by all the member organisations of the basic rights that all lung cancer patients should be granted. Recognising that lung cancer is the leading cause of cancer death in both men and women world-wide; consistently it will kill more people than breast, prostate, and colon […]

Read more
siteicon
Policy On Funding Arrangements

The Global Lung Cancer Coalition (GLCC) welcomes corporate donations, grants and sponsorship to fund certain projects and to enable the Coalition to grow and develop. This document outlines GLCC’s policy on commercial funding (including the pharmaceutical industry) and provides a set of principles that will be used to guide GLCC’s decisions. It does not set […]

Read more
siteicon
Sustaining Partners

GLCC Sustaining Partners are commercial companies that want to establish a long-term relationship with the Coalition and wish to demonstrate their commitment to lung cancer patients by helping GLCC promote global understanding of the burden of lung cancer and the right of patients to effective early detection, better treatment and supportive care. A Sustaining Partner […]

Read more
siteicon
Membership

Membership of the GLCC is voluntary and for patient and professional organisations dedicated to improving lung cancer patient outcomes. Membership is open to registered non-government, patient and professional organisations involved in the advocacy, support and care for lung cancer patients. Full details of our goals and membership requirements as well an application form can be […]

Read more
siteicon
Links and Networks

The GLCC works with other organisations and networks across the globe, seeking common ground to further our aims to improve the lives of lung cancer patients. As such, we are proud to be one of the founder members of the Lung Ambition Alliance. This consists of four distinct organisations, all with extensive and complementary experience in […]

Read more
siteicon
Lung Ambition Alliance – About the LAA

The Lung Ambition Alliance consists of four distinct organisations, all with extensive and complementary experience in helping patients and healthcare professionals manage lung cancer. The LAA stands together to better understand how the disease evolves, to develop advanced therapeutic techniques, and ultimately, to empower and enable patients to live longer and better lives. The LAA is […]

Read more
siteicon
LAA – TERAVOLT Study

COVID-19 – TERAVOLT Study The global TERAVOLT registry, initiated in March 2020, aims to provide outcome data specific to patients with thoracic cancer, who contracted COVID-w19. The data collected will, hopefully, guide disease management and define factors influencing associated morbidity and mortality. The Lung Ambition Alliance has recently announced that it is providing new funding […]

Read more
siteicon
LAA – COVID-19 Resources

Resources During the current COVID-19 global health crisis, people living with lung cancer and their loved ones will have many questions. To help with these concerns, we have put together an initial list of resources Below is a link to the organizations and a visual summary of topics covered by each organization. Please consult the […]

Read more
siteicon
LAA – Global Survey into Attitudes Towards Lung Cancer

LAA global survey reveals misconceptions about lung cancer (LONDON, November 2019) – Only one in five people (22%) disagree with the statement “generally, patients with lung cancer have caused their illness through their lifestyle choices and behaviors,” according to a global, omnibus survey conducted by Ipsos MORI and sponsored by the Lung Ambition Alliance. The results were […]

Read more
siteicon
Contact Us

For membership and general enquries please contact: glcc@roycastle.org For media enquiries please contact simon.malia@roycastle.org  

Read more
global
RESEARCH - The State of Global Lung Cancer Research - 2020 data now published / NEWS - global COVID-19 updates